Preprint record
COVID 19 is the respiratory disease caused by the new coronavirus SARS CoV 2 and is characterized by clinical manifestations ranging from mild, flu like symptoms, to severe respiratory failure and multi organ failure. Patients with more severe symptoms may require intensive care treatments and have a high risk of mortality. COVID 19 is characterized by an abnormal inflammatory response similar to a cytokine storm, which is associated with endothelial dysfunction and microvascular complications. To date, no specific treatments are available for COVID 19 and its potentially life threatening complications. Ozone therapy is the administration of a mixture of ozone and oxygen, or Medical Ozone (MO), which produces a series of benefits capable of counteracting a wide range of pathologies, in use for over a century as an unconventional medicine practice. The use of Ozone therapy with the large auto hemo infusion technique could help oxygenate the tissues better, decrease lung inflammation and regulate the immune response, help slow down viral growth, regulate lung circulation and avoid or slow down vascular hypertrophy and consequent hyperemia, especially in the early stages
Giovanni T. Ranaldi, Emanuele Rocco Villani, Laura Franza and Giulia Motola (June 3, 2020). Devils and Angels: Ozonetherapy for microcirculation in covid 19. Frenxiv. https://doi.org/10.31226/osf.io/c2jvt
This record is deposited on the Open Science Framework and carries a persistent DOI. Use the links below to locate it in scholarly indexes.
Frenxiv records connect to the wider scholarly record. These services support discovery, identifiers, preservation and open licensing.